Oppenheimer & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.91M Sell
10,365
-717
-6% -$361K 0.06% 339
2025
Q4
$5.17M Sell
11,082
-1,230
-10% -$571K 0.07% 301
2025
Q3
$5.25M Sell
12,312
-423
-3% -$164K 0.06% 329
2025
Q2
$4.88M Sell
12,735
-655
-5% -$236K 0.06% 321
2025
Q1
$4.63M Buy
13,390
+121
+0.9% +$38.9K 0.07% 306
2024
Q4
$3.98M Sell
13,269
-3,925
-23% -$1.37M 0.06% 343
2024
Q3
$6.99M Sell
17,194
-628
-4% -$230K 0.11% 208
2024
Q2
$5.73M Sell
17,822
-1,492
-8% -$485K 0.09% 246
2024
Q1
$6.44M Buy
19,314
+3,423
+22% +$1.05M 0.11% 228
2023
Q4
$4.3M Sell
15,891
-4,975
-24% -$1.23M 0.08% 285
2023
Q3
$5.13M Sell
20,866
-1,106
-5% -$303K 0.11% 227
2023
Q2
$6.67M Buy
21,972
+984
+5% +$274K 0.13% 176
2023
Q1
$5.53M Sell
20,988
-980
-4% -$249K 0.12% 215
2022
Q4
$5.27M Buy
21,968
+4,736
+27% +$1.06M 0.12% 207
2022
Q3
$3.17M Sell
17,232
-1,310
-7% -$261K 0.07% 317
2022
Q2
$3.12M Buy
18,542
+609
+3% +$131K 0.07% 343
2022
Q1
$4.5M Sell
17,933
-3,336
-16% -$838K 0.08% 290
2021
Q4
$5.46M Buy
21,269
+112
+0.5% +$27.4K 0.1% 245
2021
Q3
$5.14M Buy
21,157
+169
+0.8% +$41.3K 0.1% 247
2021
Q2
$4.34M Buy
20,988
+603
+3% +$123K 0.08% 296
2021
Q1
$3.84M Buy
20,385
+589
+3% +$104K 0.08% 302
2020
Q4
$3.26M Sell
19,796
-4,637
-19% -$678K 0.07% 317
2020
Q3
$3.04M Buy
24,433
+168
+0.7% +$20.8K 0.08% 296
2020
Q2
$2.36M Sell
24,265
-4,612
-16% -$479K 0.06% 337
2020
Q1
$2.59M Sell
28,877
-233
-0.8% -$30.2K 0.08% 277
2019
Q4
$4.3M Sell
29,110
-1,413
-5% -$190K 0.11% 213
2019
Q3
$3.68M Sell
30,523
-110
-0.4% -$14.2K 0.1% 224
2019
Q2
$4.14M Sell
30,633
-292
-0.9% -$36.9K 0.11% 205
2019
Q1
$4.03M Sell
30,925
-443
-1% -$59.5K 0.11% 216
2018
Q4
$3.9M Buy
31,368
+4,480
+17% +$601K 0.12% 188
2018
Q3
$3.74M Sell
26,888
-1,311
-5% -$163K 0.1% 239
2018
Q2
$2.89M Buy
28,199
+1,234
+5% +$125K 0.08% 292
2018
Q1
$2.62M Hold
26,965
0.07% 329
2017
Q4
$2.37M Sell
26,965
-200
-0.7% -$16.1K 0.06% 338
2017
Q3
$2.16M Buy
27,165
+855
+3% +$68.8K 0.06% 369
2017
Q2
$2.29M Sell
26,310
-1,783
-6% -$151K 0.06% 358
2017
Q1
$2.5M Sell
28,093
-2,694
-9% -$225K 0.07% 328
2016
Q4
$2.28M Sell
30,787
-1,740
-5% -$130K 0.07% 341
2016
Q3
$2.46M Sell
32,527
-5,233
-14% -$401K 0.07% 320
2016
Q2
$2.91M Buy
37,760
+114
+0.3% +$9K 0.09% 277
2016
Q1
$2.94M Sell
37,646
-413
-1% -$28.8K 0.09% 255
2015
Q4
$2.57M Sell
38,059
-12,364
-25% -$862K 0.08% 295
2015
Q3
$3.9M Buy
50,423
+4,814
+11% +$426K 0.12% 198
2015
Q2
$4.14M Sell
45,609
-8,464
-16% -$678K 0.12% 211
2015
Q1
$4.07M Buy
54,073
+19,266
+55% +$1.38M 0.11% 218
2014
Q4
$2.56M Sell
34,807
-7,266
-17% -$511K 0.07% 320
2014
Q3
$2.97M Sell
42,073
-6,789
-14% -$449K 0.09% 272
2014
Q2
$2.75M Sell
48,862
-2,994
-6% -$158K 0.08% 286
2014
Q1
$2.72M Sell
51,856
-824
-2% -$41K 0.08% 293
2013
Q4
$2.51M Buy
52,680
+10,683
+25% +$494K 0.08% 299
2013
Q3
$1.79M Buy
41,997
+2,853
+7% +$111K 0.06% 349
2013
Q2
$1.41M Buy
+39,144
New +$1.51M 0.05% 400

Other funds holding HCA

Oppenheimer & Co's HCA Position: Q1 2026 in Review

Oppenheimer & Co reduced its HCA Healthcare (HCA) stake by 6.5% in Q1 2026, selling an estimated $361K and leaving 10,365 shares worth $4.91M. The position accounts for 0.06% of the portfolio, ranked #339.

Oppenheimer & Co first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.99M in Q3 2024. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Oppenheimer & Co held 10,365 shares of HCA Healthcare worth $4.91M as of Q1 2026.
  • Oppenheimer & Co sold 717 HCA Healthcare shares in Q1 2026, an estimated $361K.
  • HCA Healthcare made up 0.06% of Oppenheimer & Co's portfolio in Q1 2026, its #339 holding.
  • Oppenheimer & Co first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's HCA Healthcare position peaked at $6.99M in Q3 2024.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.